Director/PDMR Shareholding

RNS Number : 9686L

MGC Pharmaceuticals Limited

18 May 2022

 

MGC Pharmaceuticals Ltd.

PDMR Notification

18 May 2022

ASX, LSE: MXC

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Person Discharging Managerial Responsibilities (PDMR) has dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.

The shares the subject of this notice were issued to the PDMR in accordance with a Share Purchase Agreement executed by MGC Pharma and the owners of MediCaNL Inc in April 2021, with the issued shares being the final tranche of deferred consideration payable by MGC Pharma to the PDMR who was a shareholder of MediCaNL Inc.

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Nadya Lisovoder
2	Reason for the notification
(a)	Position		Chief Medical Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for a corporate entity acquired by the Issuer.
(d)	Currency	Price		Volume	Total
	AUD	$0.067		6,721,179	450,319
	Aggregated information
	AUD	$0.067		6,721,179	450,319
(e)	Date of transaction		2022-05-13
(f)	Place of transaction		Outside a trading venue

--Ends--

Authorised for release by the Executive Chair, for further information please contact:

MGC Pharmaceuticals Ltd Roby Zomer CEO & Managing Director [phone] [e-mail]	MGC Pharmaceuticals Ltd David Lim Company Secretary [phone] [e-mail]
UK Broker - Turner Pope Andy Thacker [phone] [e-mail]	UK PR Advisors - Tavistock Charles Vivian / Tim Pearson [phone] [e-mail]

 

END

 

 

DSHBBGDUSGBDGDI